Cargando…

Role of surgery in patients with early stage small-cell lung cancer

PURPOSE: Currently, systemic chemotherapy combined with thoracic radiation is the standard treatment for patients with small-cell lung cancer (SCLC). However, the treatment of early stage SCLC remains controversial. This study evaluated the survival outcomes of surgical treatments and the effect of...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Aimei, Li, Guoshu, Xiong, Mengting, Xie, Shuanshuan, Wang, Changhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667680/
https://www.ncbi.nlm.nih.gov/pubmed/31440096
http://dx.doi.org/10.2147/CMAR.S202283
_version_ 1783440076222496768
author Peng, Aimei
Li, Guoshu
Xiong, Mengting
Xie, Shuanshuan
Wang, Changhui
author_facet Peng, Aimei
Li, Guoshu
Xiong, Mengting
Xie, Shuanshuan
Wang, Changhui
author_sort Peng, Aimei
collection PubMed
description PURPOSE: Currently, systemic chemotherapy combined with thoracic radiation is the standard treatment for patients with small-cell lung cancer (SCLC). However, the treatment of early stage SCLC remains controversial. This study evaluated the survival outcomes of surgical treatments and the effect of adjuvant chemotherapy and radiotherapy on lung cancer-specific survival (LCSS) in patients with early stage SCLC. METHODS: Using the Surveillance, Epidemiology, and End Results registry, we identified 2,453 patients with early stage SCLC (1,295 women and 1,158 men) who had complete clinical information between 2004 and 2015. The Kaplan-Meier analysis was used to determine the propensity score based on the characteristics of patients with early stage SCLC. LCSS was compared between patients treated with surgery and non-surgery after adjusting, stratifying, or matching patients with early stage SCLC. In addition, we compared the effects of chemotherapy and radiotherapy on LCSS in patients with early stage SCLC. RESULTS: Overall, 687 (28.0%) and 1,766 (72.0%) patients with early stage SCLC did and did not undergo surgery, respectively. Kaplan-Meier analysis demonstrated a statistically significant difference in survival curves between the surgery and non-surgery groups (log-rank p<0.001). Compared with the non-surgery group, the LCSS of the surgery group was better (hazard ratio [HR]:0.494, 95% confidence interval [CI]:0.415–0.587, p<0.001) in patients with early stage SCLC when using a Cox model for multivariate analysis. There was no statistically significant difference (p=0.847) in LCSS between patients with early stage SCLC with and without chemotherapy in the multivariate analysis. Radiotherapy had favorable effects on LCSS (HR: 0.579, 95% CI: 0.500–0.671, p<0.001) in patients with early stage SCLC using multivariate analysis. CONCLUSIONS: Our study results suggest that LCSS conferred by surgery was higher than that conferred by non-surgery and that radiotherapy is associated with better survival in patients with early stage SCLC. This study findings should be confirmed in prospective studies.
format Online
Article
Text
id pubmed-6667680
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66676802019-08-22 Role of surgery in patients with early stage small-cell lung cancer Peng, Aimei Li, Guoshu Xiong, Mengting Xie, Shuanshuan Wang, Changhui Cancer Manag Res Original Research PURPOSE: Currently, systemic chemotherapy combined with thoracic radiation is the standard treatment for patients with small-cell lung cancer (SCLC). However, the treatment of early stage SCLC remains controversial. This study evaluated the survival outcomes of surgical treatments and the effect of adjuvant chemotherapy and radiotherapy on lung cancer-specific survival (LCSS) in patients with early stage SCLC. METHODS: Using the Surveillance, Epidemiology, and End Results registry, we identified 2,453 patients with early stage SCLC (1,295 women and 1,158 men) who had complete clinical information between 2004 and 2015. The Kaplan-Meier analysis was used to determine the propensity score based on the characteristics of patients with early stage SCLC. LCSS was compared between patients treated with surgery and non-surgery after adjusting, stratifying, or matching patients with early stage SCLC. In addition, we compared the effects of chemotherapy and radiotherapy on LCSS in patients with early stage SCLC. RESULTS: Overall, 687 (28.0%) and 1,766 (72.0%) patients with early stage SCLC did and did not undergo surgery, respectively. Kaplan-Meier analysis demonstrated a statistically significant difference in survival curves between the surgery and non-surgery groups (log-rank p<0.001). Compared with the non-surgery group, the LCSS of the surgery group was better (hazard ratio [HR]:0.494, 95% confidence interval [CI]:0.415–0.587, p<0.001) in patients with early stage SCLC when using a Cox model for multivariate analysis. There was no statistically significant difference (p=0.847) in LCSS between patients with early stage SCLC with and without chemotherapy in the multivariate analysis. Radiotherapy had favorable effects on LCSS (HR: 0.579, 95% CI: 0.500–0.671, p<0.001) in patients with early stage SCLC using multivariate analysis. CONCLUSIONS: Our study results suggest that LCSS conferred by surgery was higher than that conferred by non-surgery and that radiotherapy is associated with better survival in patients with early stage SCLC. This study findings should be confirmed in prospective studies. Dove 2019-07-26 /pmc/articles/PMC6667680/ /pubmed/31440096 http://dx.doi.org/10.2147/CMAR.S202283 Text en © 2019 Peng et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Peng, Aimei
Li, Guoshu
Xiong, Mengting
Xie, Shuanshuan
Wang, Changhui
Role of surgery in patients with early stage small-cell lung cancer
title Role of surgery in patients with early stage small-cell lung cancer
title_full Role of surgery in patients with early stage small-cell lung cancer
title_fullStr Role of surgery in patients with early stage small-cell lung cancer
title_full_unstemmed Role of surgery in patients with early stage small-cell lung cancer
title_short Role of surgery in patients with early stage small-cell lung cancer
title_sort role of surgery in patients with early stage small-cell lung cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667680/
https://www.ncbi.nlm.nih.gov/pubmed/31440096
http://dx.doi.org/10.2147/CMAR.S202283
work_keys_str_mv AT pengaimei roleofsurgeryinpatientswithearlystagesmallcelllungcancer
AT liguoshu roleofsurgeryinpatientswithearlystagesmallcelllungcancer
AT xiongmengting roleofsurgeryinpatientswithearlystagesmallcelllungcancer
AT xieshuanshuan roleofsurgeryinpatientswithearlystagesmallcelllungcancer
AT wangchanghui roleofsurgeryinpatientswithearlystagesmallcelllungcancer